212 related articles for article (PubMed ID: 20416277)
1. Hinokitiol activates the hypoxia-inducible factor (HIF) pathway through inhibition of HIF hydroxylases.
Lee MJ; Kim JW; Yang EG
Biochem Biophys Res Commun; 2010 May; 396(2):370-5. PubMed ID: 20416277
[TBL] [Abstract][Full Text] [Related]
2. Hinokitiol increases the angiogenic potential of dental pulp cells through ERK and p38MAPK activation and hypoxia-inducible factor-1α (HIF-1α) upregulation.
Kim MK; Park HJ; Kim YD; Ryu MH; Takata T; Bae SK; Bae MK
Arch Oral Biol; 2014 Feb; 59(2):102-10. PubMed ID: 24370180
[TBL] [Abstract][Full Text] [Related]
3. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha.
Dayan F; Roux D; Brahimi-Horn MC; Pouyssegur J; Mazure NM
Cancer Res; 2006 Apr; 66(7):3688-98. PubMed ID: 16585195
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
Hewitson KS; Schofield CJ; Ratcliffe PJ
Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
[TBL] [Abstract][Full Text] [Related]
5. Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase.
Jeon H; Kim H; Choi D; Kim D; Park SY; Kim YJ; Kim YM; Jung Y
Mol Pharmacol; 2007 Jun; 71(6):1676-84. PubMed ID: 17377063
[TBL] [Abstract][Full Text] [Related]
6. Baicalein induces functional hypoxia-inducible factor-1alpha and angiogenesis.
Cho H; Lee HY; Ahn DR; Kim SY; Kim S; Lee KB; Lee YM; Park H; Yang EG
Mol Pharmacol; 2008 Jul; 74(1):70-81. PubMed ID: 18426858
[TBL] [Abstract][Full Text] [Related]
7. Leu-574 of human HIF-1alpha is a molecular determinant of prolyl hydroxylation.
Kageyama Y; Koshiji M; To KK; Tian YM; Ratcliffe PJ; Huang LE
FASEB J; 2004 Jun; 18(9):1028-30. PubMed ID: 15084514
[TBL] [Abstract][Full Text] [Related]
8. Effects of polynitrogen compounds on the activity of recombinant human HIF-1α prolyl hydroxylase 3 in E. coli.
Geng Z; Zhu J; Cao J; Geng J; Song X; Zhang Z; Bian N; Wang Z
J Inorg Biochem; 2011 Mar; 105(3):391-9. PubMed ID: 21421125
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of a prolyl hydroxylase domain (PHD) by substrate analog peptides.
Kwon HS; Choi YK; Kim JW; Park YK; Yang EG; Ahn DR
Bioorg Med Chem Lett; 2011 Jul; 21(14):4325-8. PubMed ID: 21665470
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
[TBL] [Abstract][Full Text] [Related]
11. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
[TBL] [Abstract][Full Text] [Related]
12. HIF-prolyl hydroxylases and cardiovascular diseases.
Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
[TBL] [Abstract][Full Text] [Related]
13. HIF hydroxylation and cellular oxygen sensing.
Metzen E; Ratcliffe PJ
Biol Chem; 2004; 385(3-4):223-30. PubMed ID: 15134335
[TBL] [Abstract][Full Text] [Related]
14. Manganese (II) induces chemical hypoxia by inhibiting HIF-prolyl hydroxylase: implication in manganese-induced pulmonary inflammation.
Han J; Lee JS; Choi D; Lee Y; Hong S; Choi J; Han S; Ko Y; Kim JA; Kim YM; Jung Y
Toxicol Appl Pharmacol; 2009 Mar; 235(3):261-7. PubMed ID: 19263519
[TBL] [Abstract][Full Text] [Related]
15. Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway.
Hirsilä M; Koivunen P; Xu L; Seeley T; Kivirikko KI; Myllyharju J
FASEB J; 2005 Aug; 19(10):1308-10. PubMed ID: 15941769
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.
Loinard C; Ginouvès A; Vilar J; Cochain C; Zouggari Y; Recalde A; Duriez M; Lévy BI; Pouysségur J; Berra E; Silvestre JS
Circulation; 2009 Jul; 120(1):50-9. PubMed ID: 19546390
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites.
Pappalardi MB; McNulty DE; Martin JD; Fisher KE; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Schwartz B; Annan RS; Copeland RA; Tummino PJ; Luo L
Biochem J; 2011 Jun; 436(2):363-9. PubMed ID: 21410436
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger.
Choi KO; Lee T; Lee N; Kim JH; Yang EG; Yoon JM; Kim JH; Lee TG; Park H
Mol Pharmacol; 2005 Dec; 68(6):1803-9. PubMed ID: 16155211
[TBL] [Abstract][Full Text] [Related]
19. Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth.
Erez N; Milyavsky M; Eilam R; Shats I; Goldfinger N; Rotter V
Cancer Res; 2003 Dec; 63(24):8777-83. PubMed ID: 14695194
[TBL] [Abstract][Full Text] [Related]
20. Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases.
Cho EA; Song HK; Lee SH; Chung BH; Lim HM; Lee MK
J Cell Biochem; 2013 Apr; 114(4):864-73. PubMed ID: 23097160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
